Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$9.32 - $15.06 $24,399 - $39,427
-2,618 Reduced 27.77%
6,808 $66,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $18.13 $22,362 - $32,434
1,789 Added 23.43%
9,426 $138,000
Q3 2022

Nov 14, 2022

BUY
$11.57 - $15.59 $590 - $795
51 Added 0.67%
7,637 $93,000
Q2 2022

Aug 12, 2022

SELL
$8.45 - $14.84 $2,577 - $4,526
-305 Reduced 3.87%
7,586 $106,000
Q1 2022

May 16, 2022

SELL
$11.38 - $21.88 $5,280 - $10,152
-464 Reduced 5.55%
7,891 $112,000
Q4 2021

Feb 14, 2022

BUY
$19.66 - $28.11 $36,823 - $52,650
1,873 Added 28.9%
8,355 $176,000
Q3 2021

Nov 15, 2021

SELL
$25.71 - $35.24 $8,895 - $12,193
-346 Reduced 5.07%
6,482 $170,000
Q2 2021

Aug 10, 2021

SELL
$30.1 - $34.85 $23,598 - $27,322
-784 Reduced 10.3%
6,828 $213,000
Q1 2021

May 17, 2021

BUY
$25.89 - $44.46 $3,702 - $6,357
143 Added 1.91%
7,612 $234,000
Q4 2020

Feb 12, 2021

BUY
$23.42 - $39.5 $174,923 - $295,025
7,469 New
7,469 $256,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $51.2M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.